[144] Legend Biotech Corp SEC Filing
Form 144 notice for Legend Biotech Corp (LEGN) reports a proposed sale of 1,000 American Depositary Shares through Fidelity Brokerage Services with an aggregate market value of $33,285 and an approximate sale date of 09/26/2025 on NASDAQ. The shares were acquired on 06/20/2022 as restricted stock vesting from the issuer and were paid as compensation. The filing lists 367,298,315 shares outstanding for the class and discloses a prior sale by Patrick Casey of 1,000 ADS on 06/26/2025 for $33,234. The filer signs the required representation that they are unaware of material nonpublic information.
La notifica Form 144 per Legend Biotech Corp (LEGN) riferisce una vendita proposta di 1.000 American Depositary Shares tramite Fidelity Brokerage Services con un valore di mercato aggregato di $33.285 e una data di vendita approssimativa il 26/09/2025 su NASDAQ. Le azioni sono state acquisite il 20/06/2022 come restricted stock vesting dall’emittente e sono state pagate come compenso. La pratica segnala 367.298.315 azioni in circolazione per la classe e rivela una vendita precedente di Patrick Casey di 1.000 ADS il 26/06/2025 per $33.234. Il dichiarante firma la rappresentazione richiesta attestando di non possedere informazioni non pubbliche materiali.
La notificación Form 144 para Legend Biotech Corp (LEGN) informa de una venta propuesta de 1,000 American Depositary Shares a través de Fidelity Brokerage Services con un valor de mercado agregado de $33,285 y una fecha de venta aproximada del 26/09/2025 en NASDAQ. Las acciones se adquirieron el 20/06/2022 como restricted stock vesting del emisor y se pagaron como compensación. La presentación indica 367,298,315 acciones en circulación para la clase y divulga una venta previa de Patrick Casey de 1,000 ADS el 26/06/2025 por $33,234. El declarante firma la representación requerida de que no tiene información material no pública.
Legend Biotech Corp (LEGN)의 Form 144 통지는 Fidelity Brokerage Services를 통해 1,000주 American Depositary Shares의 매각 제안을 보고하며, 총 시장가치 $33,285이고 NASDAQ에서 2025-09-26에 매각될 것으로 예측됩니다. 주식은 발행사로부터 제한된 주식의 권리 행사로 2022-06-20에 취득되었고 보상으로 지급되었습니다. 제출서는 해당 클래스의 367,298,315주의 유통 주식을 표시하고, Patrick Casey가 1,000 ADS를 2025-06-26에 $33,234에 매각한 선매를 공개합니다. 제출자는 중대한 비공개 정보에 해당하지 않는다는 필수 진술에 서명합니다.
L’avis Form 144 pour Legend Biotech Corp (LEGN) indique une vente proposée de 1 000 American Depositary Shares via Fidelity Brokerage Services, avec une valeur marchande agrégée de 33 285 dollars et une date de vente approximative le 26/09/2025 sur le NASDAQ. Les actions ont été acquises le 20/06/2022 en tant qu’actions restreintes acquises par vesting de l’émetteur et versées à titre de rémunération. Le dossier indique 367 298 315 actions en circulation pour la catégorie et révèle une vente antérieure par Patrick Casey de 1 000 ADS le 26/06/2025 pour 33 234 dollars. Le déclarant signe l’attestation requise indiquant qu’il n’est pas au courant d’informations non publiques importantes.
Form 144 Hinweis für Legend Biotech Corp (LEGN) meldet einen vorgeschlagenen Verkauf von 1.000 American Depositary Shares über Fidelity Brokerage Services mit einem aggregierten Marktwert von $33.285 und einem ungefähren Verkaufstermin am 26.09.2025 an der NASDAQ. Die Aktien wurden am 20.06.2022 als restricted stock vesting vom Emittenten erworben und als Vergütung gezahlt. Die Anmeldung listet 367.298.315 ausstehende Aktien für die Klasse und offenbart einen vorherigen Verkauf durch Patrick Casey von 1.000 ADS am 26.06.2025 für $33.234. Der Meldende unterschreibt die erforderliche Erklärung, dass er nicht über wesentliche nicht-öffentliche Informationen verfügt.
إشعار Form 144 لشركة Legend Biotech Corp (LEGN) يذكر بيعًا مقترحًا لـ 1,000 American Depositary Shares عبر Fidelity Brokerage Services بقيمة سوقية إجمالية قدرها $33,285 وتاريخ بيع تقريبي في 26/09/2025 في NASDAQ. تم شراء الأسهم في 20/06/2022 كـ أسهم مقيدة vesting من الجهة المصدرة وبُدِلت كتعويض. يذكر الملف 367,298,315 سهمًا قائمًا للأصناف ويسرّ مبيعًا سابقًا من Patrick Casey لـ 1,000 ADS في 26/06/2025 مقابل $33,234. يوقّع المبلغون على البيان بما يفيد أنهم ليس لديهم معلومات غير عامة مادية.
Legend Biotech Corp (LEGN) 的 Form 144 通知报告通过 Fidelity Brokerage Services 拟出售 1,000 股 American Depositary Shares,总市值 33,285 美元,预计出售日期为 2025-09-26,在 NASDAQ 上交易。该等股票于 2022-06-20 以发行人提供的受限股票归属形式取得,作为 薪酬 支付。申报中列出该类别的流通股数为 367,298,315 股,并披露 Patrick Casey 于 2025-06-26 出售 1,000 ADS,金额为 $33,234。申报人签署所需声明,表示他并不知悉重大未公开信息。
- Full Rule 144 disclosure provided including broker, acquisition details, and prior three-month sale
- Securities were acquired via restricted stock vesting, clearly stated as compensation
- Insider sale occurred: prior sale of 1,000 ADS on 06/26/2025 is disclosed
Insights
TL;DR: Routine Rule 144 disclosure of an insider sale; filing documents acquisition source and recent sale, satisfying disclosure requirements.
The Form 144 provides the standard items required under Rule 144: identity of broker, number of ADS to be sold, aggregate market value, acquisition date and nature of acquisition, and a prior sale within the three-month lookback period. The filing explicitly states the shares were acquired via restricted stock vesting on 06/20/2022 and identifies the prior sale on 06/26/2025. From a compliance perspective, the document appears complete for a notice of proposed sale and includes the attestation regarding material nonpublic information. No regulatory exceptions or special conditions are disclosed in the filing.
TL;DR: Insiders disclosed a small sale of 1,000 ADS; the item is a routine liquidity event with limited apparent market impact.
The notice shows an insider intends to sell 1,000 American Depositary Shares via Fidelity with an indicated aggregate market value of $33,285. The shares were granted through restricted stock vesting and treated as compensation. The filing also records a previous sale of 1,000 ADS on 06/26/2025 for $33,234. The information supplied is factual and concise; it does not include company financials or forward-looking statements, so its informational impact on the broader investment case is limited based on the filing contents alone.
La notifica Form 144 per Legend Biotech Corp (LEGN) riferisce una vendita proposta di 1.000 American Depositary Shares tramite Fidelity Brokerage Services con un valore di mercato aggregato di $33.285 e una data di vendita approssimativa il 26/09/2025 su NASDAQ. Le azioni sono state acquisite il 20/06/2022 come restricted stock vesting dall’emittente e sono state pagate come compenso. La pratica segnala 367.298.315 azioni in circolazione per la classe e rivela una vendita precedente di Patrick Casey di 1.000 ADS il 26/06/2025 per $33.234. Il dichiarante firma la rappresentazione richiesta attestando di non possedere informazioni non pubbliche materiali.
La notificación Form 144 para Legend Biotech Corp (LEGN) informa de una venta propuesta de 1,000 American Depositary Shares a través de Fidelity Brokerage Services con un valor de mercado agregado de $33,285 y una fecha de venta aproximada del 26/09/2025 en NASDAQ. Las acciones se adquirieron el 20/06/2022 como restricted stock vesting del emisor y se pagaron como compensación. La presentación indica 367,298,315 acciones en circulación para la clase y divulga una venta previa de Patrick Casey de 1,000 ADS el 26/06/2025 por $33,234. El declarante firma la representación requerida de que no tiene información material no pública.
Legend Biotech Corp (LEGN)의 Form 144 통지는 Fidelity Brokerage Services를 통해 1,000주 American Depositary Shares의 매각 제안을 보고하며, 총 시장가치 $33,285이고 NASDAQ에서 2025-09-26에 매각될 것으로 예측됩니다. 주식은 발행사로부터 제한된 주식의 권리 행사로 2022-06-20에 취득되었고 보상으로 지급되었습니다. 제출서는 해당 클래스의 367,298,315주의 유통 주식을 표시하고, Patrick Casey가 1,000 ADS를 2025-06-26에 $33,234에 매각한 선매를 공개합니다. 제출자는 중대한 비공개 정보에 해당하지 않는다는 필수 진술에 서명합니다.
L’avis Form 144 pour Legend Biotech Corp (LEGN) indique une vente proposée de 1 000 American Depositary Shares via Fidelity Brokerage Services, avec une valeur marchande agrégée de 33 285 dollars et une date de vente approximative le 26/09/2025 sur le NASDAQ. Les actions ont été acquises le 20/06/2022 en tant qu’actions restreintes acquises par vesting de l’émetteur et versées à titre de rémunération. Le dossier indique 367 298 315 actions en circulation pour la catégorie et révèle une vente antérieure par Patrick Casey de 1 000 ADS le 26/06/2025 pour 33 234 dollars. Le déclarant signe l’attestation requise indiquant qu’il n’est pas au courant d’informations non publiques importantes.
Form 144 Hinweis für Legend Biotech Corp (LEGN) meldet einen vorgeschlagenen Verkauf von 1.000 American Depositary Shares über Fidelity Brokerage Services mit einem aggregierten Marktwert von $33.285 und einem ungefähren Verkaufstermin am 26.09.2025 an der NASDAQ. Die Aktien wurden am 20.06.2022 als restricted stock vesting vom Emittenten erworben und als Vergütung gezahlt. Die Anmeldung listet 367.298.315 ausstehende Aktien für die Klasse und offenbart einen vorherigen Verkauf durch Patrick Casey von 1.000 ADS am 26.06.2025 für $33.234. Der Meldende unterschreibt die erforderliche Erklärung, dass er nicht über wesentliche nicht-öffentliche Informationen verfügt.